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Abstract. 
 
Small GTP-binding proteins such as ADP-
ribosylation factor 1 (ARF1) and Sar1p regulate the 
membrane association of coat proteins involved in in-
tracellular membrane trafficking. ARF1 controls the 
clathrin coat adaptor AP-1 and the nonclathrin coat 
COPI, whereas Sar1p controls the nonclathrin coat 
COPII. In this study, we demonstrate that membrane 
association of the recently described AP-3 adaptor is 
regulated by ARF1. Association of AP-3 with mem-
branes in vitro
 
 
 
was enhanced by GTP
 
g
 
S and inhibited 
by brefeldin A (BFA), an inhibitor of ARF1 guanine 
nucleotide exchange. In addition, recombinant myris-
toylated ARF1 promoted association of AP-3 with 
membranes. The role of ARF1 in vivo was examined by 
assessing AP-3 subcellular localization when the intra-
cellular level of ARF1-GTP was altered through 
overexpression of dominant ARF1 mutants or ARF1-
GTPase-activating protein (GAP). Lowering ARF1-
GTP levels resulted in redistribution of AP-3 from 
punctate membrane-bound structures to the cytosol as 
seen by immunofluorescence microscopy. In contrast, 
increasing ARF1-GTP levels prevented redistribution 
of AP-3 to the cytosol induced by BFA or energy de-
pletion. Similar experiments with mutants of ARF5 and 
ARF6 showed that these other ARF family members 
had little or no effect on AP-3. Taken together, our re-
sults indicate that membrane recruitment of AP-3 is 
promoted by ARF1-GTP. This finding suggests that 
ARF1 is not a regulator of specific coat proteins, but 
rather is a ubiquitous molecular switch that acts as a 
transducer of diverse signals influencing coat assembly.
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T
 
he
 
 trafficking of integral membrane proteins to
their final destinations within the cell is mediated by
membrane-bound carrier intermediates. Formation
of these intermediates is initiated by deposition of coat
proteins on the cytosolic face of the membrane at the ap-
propriate intracellular location (for reviews see Rothman
and Wieland, 1996; Schekman and Orci, 1996). Coat pro-
teins participate in two crucial events in the trafficking
process, namely the physical formation of transport inter-
mediates and the selection of cargo for transport (for re-
views see Bednarek et al., 1996; Kirchhausen et al., 1997;
Schmid, 1997). Several protein coats have been identified,
and are broadly classified as either clathrin or nonclathrin
coats. Clathrin coats comprise clathrin and its associated
adaptor proteins (APs)
 
1
 
 (Pearse and Robinson, 1990).
Two different clathrin coats containing either AP-2 or AP-1
adaptors mediate, respectively, endocytosis from the plasma
membrane and transport from the TGN to endosomes and
lysosomes (Keen, 1990; Kirchhausen, 1993; Robinson, 1994;
Marks et al., 1995). The nonclathrin coats COPI and COPII
participate in ER–Golgi pathways and in transport along
the endocytic route (for reviews see Cosson and Letourneur,
1997; Kuehn and Schekman, 1997). Other coats present on
the TGN have been described but are not as well charac-
terized (Jones et al., 1993; Narula and Stow, 1995; Traub
and Kornfeld, 1997).
We (Dell’Angelica et al., 1997
 
a
 
) and others (Simpson
et al., 1997) have recently described a third adaptor com-
plex, AP-3, which is involved in the biogenesis of special-
ized organelles such as pigment granules and synaptic ves-
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Abbreviations used in this paper
 
: AP, adaptor protein; ARF, ADP-ribo-
sylation factor; BFA, brefeldin A; CB, coat-binding; DOG, 2-deoxyglu-
cose; GAP, GTPase-activating protein; GEF, guanine nucleotide ex-
change factor; HA, hemagglutinin; HB, homogenization buffer; HMW,
high molecular weight. 
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icles (Ooi et al., 1997; Simpson et al., 1997; Faúndez et al.,
1998), and in the delivery of proteins to the yeast vacuole
(Cowles et al., 1997; Stepp et al., 1997). The AP-1, AP-2,
and AP-3 adaptor complexes have a similar four-subunit
composition, each with two large chains (100–160 kD), a
medium chain (
 
z
 
50 kD), and a small chain (
 
z
 
20 kD). The
corresponding subunits of AP-1, AP-2, and AP-3 have
structural homology to each other, and are named, respec-
tively, 
 
g
 
, 
 
a
 
, 
 
d
 
 and 
 
b
 
1, 
 
b
 
2, 
 
b
 
3 (large chains); 
 
m
 
1, 
 
m
 
2, 
 
m
 
3 (me-
dium chains); and 
 
s
 
1, 
 
s
 
2, 
 
s
 
3 (small chains). The 
 
b
 
 chains
associate physically with clathrin (Ahle and Ungewickell,
1989; Gallusser and Kirchhausen, 1993; Shih et al., 1995;
Wilde and Brodsky, 1996; Dell’Angelica et al., 1998),
whereas the 
 
a
 
, 
 
g
 
, and 
 
d
 
 chains are believed to bind to a pu-
tative docking site that directs them to the appropriate in-
tracellular membranes (Robinson, 1993; Chang et al.,
1993; Page and Robinson, 1995). In addition to providing a
link between clathrin and the membrane, adaptor com-
plexes also select transport cargo. This function is im-
parted by the ability of these complexes to recognize ty-
rosine- and dileucine-based sorting signals present in the
cytosolic tails of integral membrane proteins (Ohno et al.,
1995; Boll et al., 1996; Heilker et al., 1996; Dietrich et al.,
1997; Marks et al., 1997). In particular, the 
 
m
 
 chains have
been identified as the subunits of the adaptor complexes
that directly recognize tyrosine-based signals (Ohno et al.,
1995, 1996). Thus, the adaptor complexes coordinate the
multiple functions of coat proteins through the roles of
each of their subunits.
Besides their similarity to each other, the adaptor coat
complexes also have structural homology, although to a
lesser extent, to the components of COPI. Indeed, the 
 
b
 
, 
 
d
 
,
and 
 
z
 
 chains of COPI are homologous to the 
 
b
 
, 
 
m
 
, and 
 
s
 
chains of the adaptor complexes, respectively (Duden et al.,
1991; Serafini et al., 1991; Cosson et al., 1996). The obser-
vation that many protein coats are structurally related but
distinct has led to the concept that the intracellular traf-
ficking machinery uses similar basic mechanisms which are
iterated with variations to confer specificity to different
transport pathways.
Further support for this concept is provided by small
GTP-binding proteins that act as molecular switches in
regulating intracellular traffic. The rab family comprises a
group of structurally related proteins that participate in
vesicle fusion and probably other transport events (for re-
view see Novick and Zerial, 1997). Different rab family
members are found at different intracellular locations and
act on distinct trafficking pathways. Another group of
small GTP-binding proteins regulate the recruitment of
different coat proteins from the cytosol to the appropriate
membranes (for reviews see Donaldson and Klausner,
1994; Bednarek et al., 1996). In each case, the cycle of
GTP binding and hydrolysis controls association of the
GTP-binding protein itself to membranes; this association
in turn promotes binding of coat. However, in contrast to
a model for the rab proteins whereby different family
members regulate distinct traffic systems, the picture is
more complicated for the GTP-binding proteins that con-
trol coat recruitment. A single protein, ADP-ribosylation
factor 1 (ARF1), has been shown to regulate at least two
different classes of coats, including clathrin (AP-1) and non-
clathrin (COPI) coats, and at multiple intracellular locations
(Lenhard et al., 1992; Donaldson and Klausner, 1994;
Boman and Kahn, 1995; Dittie et al., 1996; Faúndez et al.,
1997), even though there exists other closely-related ARF
family members (Kahn et al., 1991; Tsuchiya et al., 1991).
In addition, a GTP-binding protein that has structural ho-
mology to ARF but which is not from the ARF family,
Sar1p, regulates another nonclathrin coat (COPII) (for re-
views see Salama and Schekman, 1995; Bednarek et al.,
1996), whereas the clathrin coat adaptor AP-2 does not ap-
pear to be regulated in vivo by an ARF protein (Robinson
and Kreis, 1992; Wong and Brodsky, 1992). Thus, studies
up to this point have failed to provide a coherent picture
regarding control of diverse coat proteins by small GTP-
binding proteins.
In this study, we investigate the regulation of membrane
recruitment of the newly identified AP-3 adaptor. We find
that ARF1, the same protein that regulates two other
coats, also regulates AP-3. These results support the con-
cept that ARF1 is a common regulator in the pathways
governing recruitment of diverse coat proteins to mem-
branes.
 
Materials and Methods
 
Cells and Reagents
 
HeLa S3 cells (American Type Culture Collection, Rockville, MD) were
cultured in suspension for preparation of membrane fractions. HeLa
(American Type Culture Collection) and MDCK II cells (gift of E. Rod-
riguez-Boulan, Cornell University Medical College, New York) were cul-
tured as monolayers in DME supplemented with 9% FBS, 100U/ml peni-
cillin, 100 
 
m
 
g/ml streptomycin, and 2 mM
 
 l
 
-glutamine. Brefeldin A (BFA)
was from Epicentre Technologies (Madison, WI) and trypsin was from
Promega Corp. (Madison, WI). GTP
 
g
 
S, ATP, creatine phosphate, and
creatine kinase were from Sigma Chemical Co. (St. Louis, MO).
 
Recombinant Proteins
 
GST Fusion with 
 
d
 
-Adaptin Fragment (GG1).  
 
DNA encoding residues 752–
839 of 
 
d
 
-adaptin was generated by PCR and then cloned into pGEX-5X-1
(Pharmacia Biotech. Inc., Piscataway, NJ). Production and purification
of the GST fusion protein using glutathione–Sepharose 4B (Pharmacia
Biotech. Inc.) was carried out according to the manufacturer’s instruc-
tions. 
 
Myristoylated ARF1.  
 
Recombinant myristoylated ARF1 was a gift of P.
Randazzo and J. Andrade (both from National Cancer Institute, NIH, Be-
thesda, MD).
 
Antibodies
 
The following commercial primary antibodies were used: (
 
a
 
) monoclonal
anti-ARF 1D9 and monoclonal anti–
 
a
 
-adaptin AP.6 (Affinity Bioreagents,
Inc., Golden, CO); (
 
b
 
) monoclonal anti–
 
g
 
-adaptin 100/3 (Sigma Chemical
Co.); and (
 
c
 
) monoclonal anti-HA 16B12 and rabbit anti-HA 11 (Berkeley
Antibody Co., Richmond, CA). Rabbit antiserum to COPI (
 
b
 
-COP) was
provided by J. Lippincott-Schwartz (NIH, Bethesda, MD). Preparation of
affinity-purified rabbit antibodies to the 
 
b
 
, 
 
m
 
, and 
 
s
 
 subunits of AP-3 have
been described previously (Dell’Angelica et al., 1997
 
a
 
,
 
b
 
). Rabbit antise-
rum to 
 
d
 
-adaptin was generated using a GST-fusion protein (GG1) con-
taining residues 752–839 of 
 
d
 
-adaptin. The antibody was affinity purified
using GG1 immobilized on Affigel-15 beads (Bio-Rad Laboratories, Her-
cules, CA), and reacted with a major 160-kD species and a minor 90-kD
species in total HeLa cell extracts and in bovine brain cytosol.
 
Membranes
 
A membrane preparation from HeLa cells enriched in endosomes was
prepared as described by Aniento et al. (1996). Cells were grown in sus-
pension to a density of 0.5 
 
3 
 
10
 
6
 
/ml and harvested by centrifugation at
2,000 rpm in a JA-10 rotor (Beckman Instrs., Palo Alto, CA). Cells were 
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washed twice in homogenization buffer (HB) (250 mM sucrose, 3 mM imi-
dazole, pH 7.4), resuspended in four-pellet volumes of ice-cold HB con-
taining protease inhibitors (0.5 mM 4-[2-aminoethyl]-benzenesulfonyl flu-
oride, 10 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml pepstatin), and then homogenized by
seven passages through a 23-gauge needle. The homogenate was centri-
fuged at 800 
 
g
 
 to yield the postnuclear supernatant. The postnuclear su-
pernatant was adjusted to 40.6% sucrose, then overlaid sequentially with
35% sucrose, 25% sucrose, and HB (all sucrose solutions contained 3 mM
imidazole, pH 7.4). The gradient was centrifuged in a SW41 rotor (Beck-
man Instrs.) at 40,000 rpm for 90 min. Membrane fractions enriched for
endosomal or Golgi membranes were collected from the 35/25% and the
40.6/35% sucrose interface, respectively (Aniento et al., 1996). Mem-
branes were washed with salt by incubation on ice for 20 min after addi-
tion of an equal volume of 2M KCl. The stripped membranes were col-
lected by centrifugation at 100,000 
 
g
 
 for 90 min, resuspended in coat-
binding (CB) buffer (see 
 
In Vitro Membrane-binding Assay
 
), and then
stored in liquid nitrogen. Protein quantitation was performed with the
Bradford reagent (Bio-Rad Laboratories) using bovine serum albumin as
a standard. Enrichment for endosomal membranes was confirmed by im-
munoblotting for the early endosomal marker rab5.
 
Bovine Brain Cytosol Preparation and Fractionation
 
Bovine brain homogenates were prepared in 0.1 M sodium 2-(N-mor-
pholino)ethanesulfonate, pH 6.5, 1 mM EGTA, 0.5 mM MgCl
 
2
 
, 1 mM
4-(2-aminoethyl)-benzenesulfonyl fluoride, 0.02% (wt/vol) sodium azide,
with the aid of a tissue blender. The cytosolic fraction was obtained by
centrifugation of the homogenate at 16,000 
 
g
 
 for 40 min followed by a sec-
ond centrifugation step at 105,000 
 
g
 
 for 90 min, at 4
 
8
 
C. This fraction (30
mg/ml protein) was designated bovine brain cytosol and used in the in
vitro membrane-binding assays. To generate a high molecular weight
(HMW) fraction of the cytosol that contained AP-3 but not ARF, the cy-
tosol was subjected to gel filtration chromatography on a Superose 6 col-
umn (Pharmacia Biotech., Inc.), as described by Donaldson et al., (1992).
Fractions were analyzed by immunoblotting with AP-3 (
 
d
 
-adaptin) and
ARF antibodies. AP-3 peak fractions were pooled, concentrated fivefold
using a microconcentrator (Centricon 10; Amicon Corp., Beverly, MA),
and designated HMW fraction. These AP-3 peak fractions did not contain
ARF protein as judged by immunoblotting with ARF antibody.
 
In Vitro Membrane-binding Assay
 
The in vitro membrane-binding assay for AP-3 and ARF was carried out
in CB buffer (25 mM Hepes, pH 7.0, 0.2 M sucrose, 25 mM KCl, 2.5 mM
MgCl
 
2
 
, 1 mM DTT) supplemented with an ATP-regenerating system con-
sisting of 1 mM ATP, 5 mM creatine phosphate, and 10U/ml creatine ki-
nase. In a typical 50-
 
m
 
l reaction, 10-
 
m
 
l membranes and 10-
 
m
 
l cytosol were
used. Incubations were carried out for 20 min at 37
 
8
 
C, and the reaction
mixture was centrifuged for 10 min at 4
 
8
 
C at 14,000 
 
g
 
. The membrane pel-
let was rinsed once with buffer, resuspended in Laemmli SDS sample
buffer, heated at 95
 
8
 
C for 5 min, and then subjected to SDS-PAGE and
transferred to nitrocellulose. Immunoblotting was performed using pri-
mary antibodies as described, followed by HRP-conjugated secondary an-
tibodies (Amersham Corp., Arlington Heights, IL). The enhanced chemi-
luminescence system (Amersham) was used for detection.
 
Expression of ARF Proteins
 
All ARF plasmid constructs were in the expression vector pXS (parent
vector pCDL-SR
 
a
 
, with modified restriction sites for subcloning) (Peters
et al., 1995). Wild-type ARF1 and ARF1/Q71L were expressed using the
bovine ARF1 cDNA sequence (there is 100% amino acid identity be-
tween human and bovine ARF1). Generation of hemagglutinin (HA)-
tagged ARF1, ARF3, ARF5, ARF1/T31N, and ARF6/T27N has previ-
ously been described (Peters et al., 1995). For mutagenesis of ARF1 and
ARF5 to ARF1/Q71L and ARF5/T31N, respectively, single amino acid
substitutions were generated by PCR, using oligonucleotides bearing the
mutagenized nucleotide sequence. The PCR products were digested with
the appropriate restriction enzymes and then used to replace the corre-
sponding fragment in the wild-type cDNA-encoding proteins bearing the
HA epitope at the COOH terminus. Transient transfection of cells was
carried out by the calcium phosphate precipitation method 4–6 h after
plating on coverslips. Cells were analyzed 36–48 h after transfection.
 
Confocal Immunofluorescence Microscopy
 
Cells were fixed in 2% formaldehyde/PBS for 10 min at room tempera-
ture, washed twice with PBS, and then incubated for 5 min in 0.1% BSA/
PBS. Successive incubations with primary and secondary antibodies (di-
luted in 0.2% saponin, 0.1% BSA, PBS) were carried out for 1 h at room
temperature. Samples were rinsed with 0.1% BSA/PBS after each anti-
body incubation. After a final rinse with PBS, coverslips were mounted
with Fluoromount G (Southern Biotechnologies, Birmingham, AL). Cells
were visualized and confocal images acquired using a confocal laser scan-
ning microscope (model LSM 410; Carl Zeiss, Inc., Thornwood, NY).
Cy3-conjugated antibodies to rabbit and mouse IgG (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA) were used for visualization of
AP-1, AP-2, AP-3, and COPI staining, whereas Cy2-conjugated (Jackson
ImmunoResearch Laboratories, Inc.) or Alexa 488-conjugated (Molecu-
lar Probes, Inc., Eugene, OR) antibodies were used for detection of the
HA and 6-His epitope tags.
 
Results
 
The observation that AP-3 is found in both cytosolic and
membrane subcellular fractions, and that membrane-asso-
ciated AP-3 can be extracted with salts (Dell’Angelica et al.,
1997
 
a
 
) is consistent with its role as a membrane coat that
can be recruited from a cytosolic pool. In addition, the
punctate staining of AP-3 by immunofluorescence micros-
copy, its redistribution to the cytosol by BFA, and the re-
versibility of the BFA effect (Dell’Angelica et al., 1997
 
a
 
;
Simpson et al., 1997) also indicate that AP-3 can cycle be-
tween the cytosol and membranes. The sensitivity of AP-3
to BFA in cells suggests that its membrane association
may be regulated by ARF1, since BFA inhibits ARF1 gua-
nine nucleotide exchange, and has been shown to prevent
ARF1 membrane binding in vitro (Donaldson et al., 1992;
Helms and Rothman, 1992; Randazzo et al., 1993).
 
ARF1 Promotes Recruitment of AP-3 to Membranes
In Vitro
 
To study regulation of AP-3 association with membranes,
we first designed an in vitro membrane-binding assay. The
basic assay incubation consisted of salt-washed mem-
branes, bovine brain cytosol as a source of exogenous AP-3
and other cytosolic factors that might be required for
membrane binding, as well as an ATP-regenerating sys-
tem. Since AP-3 has been observed at or near endocytic
structures and the TGN (Simpson et al., 1996; Dell’Angel-
ica et al., 1997
 
a
 
, 1998), we first examined AP-3 binding to
sucrose gradient membrane fractions enriched in endoso-
mal or Golgi membranes (refer to Materials and Methods)
(Aniento et al., 1996). The highest AP-3 binding activity
was observed with an endosomal membrane-enriched
fraction banding at the 25–35% sucrose interface (data not
shown); this fraction was thus used in all subsequent ex-
periments. The membrane binding assays were carried out
in the absence or presence of GTP
 
g
 
S, a nonhydrolyzable
analogue of GTP that would render ARF1 and other
GTP-binding proteins in a constitutively active state.
Membranes incubated alone in the absence or presence of
GTP
 
g
 
S had no detectable AP-3 as judged by immunoblot-
ting with antibodies to all four subunits of AP-3 (
 
d
 
, 
 
b
 
3, 
 
m
 
3,
and 
 
s
 
3) (Fig. 1 
 
A
 
), indicating that these salt-washed mem-
branes do not contain any endogenous AP-3. Upon incu-
bation of membranes with cytosol, AP-3 was found associ-
ated with membranes in a GTP
 
g
 
S-enhanced manner (Fig. 
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1 
 
A
 
), implicating involvement of a GTP-binding protein
for AP-3 recruitment to membranes. In addition, using an
ARF antibody,
 
2
 
 we determined that the binding of AP-3
to membranes paralleled the binding of ARF (Fig. 1 
 
A
 
),
consistent with ARF binding being required for AP-3
binding. Binding of AP-3 to membranes was saturable,
with maximum binding occurring when 20–40 
 
m
 
l cytosol
was present in a 120-
 
m
 
l incubation mixture (Fig. 1 
 
B
 
). Un-
der these conditions, binding of ARF to membranes still
increased with increasing amounts of cytosol added, and
did not appear to be saturated (Fig. 1 
 
B
 
). This difference
in AP-3 and ARF membrane binding is consistent with
previous reports of the existence of two different popula-
tions of membrane-bound ARF, only one of which is re-
quired for coat binding (Helms et al., 1993; Finazzi et al.,
1994).
The saturability of AP-3 binding to membranes sug-
gested that it interacts with a limiting component on mem-
branes. To determine if a protein factor(s) on the mem-
branes was required for AP-3 association, we inactivated
proteins by either treating membranes with an exogenous
protease or by exposure to heat. Membranes were prein-
cubated with 0–50 
 
m
 
g/ml trypsin before addition of cyto-
sol. Binding of AP-3 was abolished upon incubation of
membranes with 
 
$
 
10 
 
m
 
g/ml trypsin, but not if the trypsin
inhibitor TPCK was present during exposure to trypsin
(Fig. 2). Inactivation of membrane proteins by incubation
at 65
 
8
 
C for 10 min also abolished AP-3 binding (Fig. 2).
Immunoblotting of ARF in the same samples showed that
ARF binding to membranes was also sensitive to trypsin
and heat treatment. Thus, binding of both ARF and AP-3
to membranes depends on the presence of a protein fac-
tor(s) on the membrane.
We next tested for the involvement of ARF1 in AP-3
membrane association. First, the effect of BFA on binding
of AP-3 to membranes was assessed. Membrane and cyto-
sol were either preincubated with BFA for 5 min before
addition of GTP
 
g
 
S for the usual assay incubation, or were
incubated with BFA for an additional 5 min after the assay
incubation in the presence of GTP
 
g
 
S. Pre-incubation with
BFA resulted in 
 
z
 
70% inhibition of ARF binding as com-
pared with samples in which BFA was added after GTP
 
g
 
S
or where no BFA was added (Fig. 3 
 
A
 
). Binding of AP-3
to membranes was similarly inhibited by BFA, with 
 
z
 
50%
inhibition observed (Fig. 3 
 
A
 
). The inhibition of AP-3 bind-
ing to membranes by BFA suggested that ARF1 is re-
quired for AP-3 membrane association.
To directly investigate the requirement for ARF1, we
assessed the ability of purified recombinant myristoylated
ARF1 to promote binding of AP-3 to membranes. An AP-
3–enriched fraction from bovine brain cytosol that was
devoid of ARF was prepared by subjecting cytosol to gel
filtration chromatography on a Superose 6 column. Frac-
tions comprising the AP-3 peak were pooled, designated
high molecular weight (HMW) fraction, and used as a
source of AP-3 in the membrane-binding assay. When
HMW fraction was incubated with membranes, no binding
of AP-3 was detected either in the absence or presence of
GTP
 
g
 
S, as assessed by immunoblotting for the 
 
s
 
3 subunit
(Fig. 3 
 
B
 
). Addition of purified recombinant myristoylated
ARF1 (50 
 
m
 
g/ml) to the incubation mixture resulted in
binding of AP-3 to membranes in the presence, but not in
the absence, of GTP
 
g
 
S (Fig. 3 
 
B
 
). Immunoblotting with
the ARF antibody showed that AP-3 binding in this exper-
iment paralleled ARF binding to membranes (Fig. 3 B).
The effect of the recombinant protein indicates that ARF1
promotes association of AP-3 with membranes in vitro.
2. The ARF antibody used (clone 1D9) recognizes all five known human
ARF proteins, but ARF1 and/or ARF3 is by far the most abundant ARF
species in cells, comprising .90% of total cellular ARF.
Figure 1. Association of AP-3
and ARF with membranes in
vitro. (A) The in vitro mem-
brane-binding assay was car-
ried out as described in
Materials and Methods. Incu-
bations were performed ei-
ther in the absence or pres-
ence of cytosol (10 ml cytosol/
50 ml reaction) and/or 25 mM
GTPgS. Bound proteins were
analyzed by immunoblotting
using antibodies to all four
subunits of AP-3 (d, b3, m3,
and s3) and to ARF (anti-
body 1D9). The two bands
detected with the s3 anti-
body probably represent the
s3A and s3B isoforms. (B)
The in vitro membrane-bind-
ing assay was carried out in 120-ml incubations containing the indi-
cated amounts of cytosol, and in the presence of 25 mM GTPgS.
Bound proteins were quantified by densitometry analysis of bands
on immunoblots and the amount bound is presented as percent of
maximum bound. Values shown for AP-3 are the average of values
obtained for all four subunits (d, b3, m3, and s3) 6 SEM. Under
conditions near saturation, 5–10% of the added AP-3 in the cytosol
bound to membranes.
Figure 2. Membrane proteins
are required for AP-3 and
ARF membrane association.
Membrane proteins were pro-
teolyzed by exposure to 0, 2, 5,
10, 25, and 50 mg/ml trypsin or
inactivated by heat (658C, 10
min). Trypsin digestion of
membrane proteins was car-
ried out for 10 min at room
temperature, in 40-ml reac-
tions comprising 10-ml membranes and 30 ml of CB buffer.
Trypsin inhibitor TPCK was added after trypsin treatment, ex-
cept for an additional sample in which TPCK was added before
addition of 50 mg/ml trypsin (1 TPCK). The treated membranes
were then used in the in vitro membrane-binding assay with cyto-
sol and GTPgS. Bound AP-3 (d and s3) and ARF were detected
by immunoblotting. The apparent higher sensitivity of the delta
subunit to trypsin treatment of membranes as compared with the
sigma subunit is reproducible and probably reflects the greater
sensitivity of the delta subunit to digestion by residual proteolytic
activity after trypsin inactivation.Ooi et al. ARF1 Regulates AP-3 Membrane Association 395
ARF1 Regulates the Localization of AP-3 in Cells
The above experiments indicate that ARF1 is required for
the membrane association of AP-3 in vitro. To determine
if ARF1 similarly regulates AP-3 in cells, we altered the
ARF1 activity in vivo by expressing dominant ARF1 mu-
tants, or by overexpressing either ARF1 or an ARF1 regu-
latory ARF1-GAP. We then assessed the effects of these
manipulations on AP-3 localization. The subcellular local-
ization of AP-3 was visualized by indirect immunofluores-
cence microscopy, using an affinity-purified antibody to
the  d-adaptin subunit of AP-3. In HeLa cells, this antibody
gave punctate staining that was slightly more pronounced
in a juxtanuclear region, but which extended to the periph-
ery of the cell. Many of these structures colocalized with
early endocytic structures stained with the transferrin re-
ceptor, as well as with clathrin, but showed little colocal-
ization with a transfected TGN marker, furin (data not
shown). This staining pattern of AP-3, and its sensitivity to
BFA (see Fig. 5 D), is similar to that previously observed
using antibodies to the s3 and b3 subunits of AP-3
(Dell’Angelica et al., 1997a, 1998).
We first expressed an HA epitope-tagged ARF1 domi-
nant-negative mutant, ARF1/T31N, by transient transfec-
tion of HeLa cells. This mutant renders endogenous ARF1
inactive, presumably by binding to and sequestering an
ARF1 guanine nucleotide exchange factor (ARF GEF),
and produces a BFA-like phenotype (Dascher and Balch,
1994; Peters et al., 1995). When expressed at high levels,
ARF1/T31N shows cytosolic staining as detected by an an-
tibody to the HA epitope. In these cells, AP-3 distribution
was no longer punctate but appeared cytosolic (Fig. 4, A
and B), reminiscent of the effect of BFA (Dell’Angelica et
al., 1997a; Simpson et al., 1997). The distribution of AP-1
was similarly affected by ARF1/T31N (Fig. 4, C and D),
whereas AP-2 distribution, which is not BFA sensitive
Figure 3. ARF1 promotes
membrane association of AP-3.
(A) BFA inhibits membrane
association of AP-3. The in
vitro membrane-binding as-
say with cytosol and mem-
branes (refer to Material and
Methods) was carried out in
the absence or presence of 25
mM GTPgS, and also in the
presence of GTPgS and 200
mM BFA. BFA was added ei-
ther before (pre) GTPgS, or
after (post) GTPgS (refer to
Results). AP-3 (d and s sub-
units) and ARF bound to
membranes were quantified
by densitometry of protein
bands from immunoblots, and
the mean values (with stan-
dard error for AP-3) in arbi-
trary units are shown (n 5 5
for AP-3; n 5 2 for ARF). The
amounts of protein bound in
the presence of cytosol and GTPgS are considered 100% binding.
(B) Recombinant ARF1 promotes membrane association of AP-3.
The in vitro membrane binding assay was carried out with mem-
branes and a high molecular weight Superose 6 fraction of bovine
brain cytosol (HMW) containing AP-3 but not ARF (refer to
Materials and Methods). Incubation reactions of 75 ml contained
15-ml membranes, 30 ml HMW, and were performed in the ab-
sence or presence of 50 mg/ml recombinant myristoylated ARF1,
with or without 25 mM of GTPgS. Bound protein (s3 for AP-3)
was assessed by immunoblotting.
Figure 4. Effect of ARF1 inactivation on subcellular localization
of AP-1, AP-2, and AP-3. HeLa cells were transiently transfected
with HA-tagged ARF1/T31N (A–F) or 6-His–tagged ARF1-GAP
(G and H), fixed, and then double labeled for the HA (A, C, and
E) or 6-His (G) epitopes and AP-3 (rabbit anti-d) (B and H), AP-1
(mouse anti–g-adaptin) (D), or AP-2 (mouse anti–a-adaptin) (F).
Fluorophore-conjugated secondary antibodies were used as de-
scribed in Materials and Methods. Cells were visualized by confo-
cal immunofluorescence microscopy. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 396
(Robinson and Kreis, 1992; Wong and Brodsky, 1992), was
not affected (Fig. 4, E and F).
As another way of inactivating ARF1 in vivo, we over-
expressed ARF1-GAP, an ARF1 regulatory protein that
activates hydrolysis of ARF1-bound GTP (Cukierman et al.,
1995). High levels of this protein would drastically reduce
the intracellular concentration of ARF1-GTP, and has
been shown to result in redistribution of coatomer from
membrane to the cytosol (Aoe et al., 1997). Cells overex-
pressing a 6-His epitope-tagged ARF1-GAP were identi-
fied by staining with antibody to the 6-His epitope. In
these cells, AP-3 distribution was cytosolic (Fig. 4, G and
H), strongly suggesting, again, that ARF1-GTP was re-
quired for membrane localization of AP-3.
To further confirm the role of ARF1 in the membrane
association of AP-3, we tested the ability of a constitu-
tively active ARF1 mutant, ARF1/Q71L, to prevent dis-
sociation of AP-3 from membranes. ARF1/Q71L has
a  markedly lowered rate of hydrolysis of bound GTP
(Dascher and Balch, 1994). Expression of such a mutant
thus effectively increases the intracellular concentration of
ARF1-GTP, and has been observed to protect coatomer
from BFA-induced membrane dissociation (Teal et al.,
1994; Zhang et al., 1994). In HeLa cells, expression of
ARF1/Q71L did not visibly alter the distribution of AP-3
(Fig. 5, A and B). Some of the AP-3–containing structures
appeared coincident with those stained with ARF1/Q71L
(Fig. 5, A and B, arrows), suggesting that AP-3 bound to
membranes at sites where ARF1/Q71L was present. HeLa
cells transiently transfected with HA-tagged ARF1/Q71L
were then subjected to two different treatments that in-
duced dissociation of AP-3 from membranes. These ma-
nipulations were BFA treatment and energy depletion (by a
combination of 50 mM 2-deoxyglucose [DOG] and 0.04%
sodium azide). In untransfected cells, treatment with either
BFA (Fig. 5, C and D) or DOG/azide (Fig. 5, E and F)
caused redistribution of AP-3 to the cytosol. In cells express-
ing ARF1/Q71L, however, AP-3 was retained on punctate
structures present throughout the cell (Fig. 5, C–F). Thus,
ARF1/Q71L protects AP-3 from membrane dissociation.
These results strongly suggest that ARF1-GTP promotes
membrane association of AP-3, consistent with the find-
ings using ARF1/T31N and ARF1-GAP.
We have so far deduced a role for ARF1 in AP-3 mem-
brane association using ARF1 mutants and an ARF1 regu-
lator. In addition, we found that we could observe a direct
effect of overexpressed wild-type ARF1 on AP-3 distribu-
tion in cells subjected to energy depletion. In cells overex-
pressing wild-type HA-tagged ARF1, AP-3 was found on
punctate structures upon energy-depletion, whereas in un-
transfected cells AP-3 was cytosolic (Fig. 5, G and H).
However, this effect was only observed under extremely
high expression levels of ARF1; thus, wild-type ARF1 was
not as potent as ARF1/Q71L in conferring protection of
AP-3 from membrane dissociation.
Effects of Other ARF Family Members on AP-3
ARF1 is one member of a family of highly conserved pro-
teins, with four other ARFs having been identified in hu-
mans (Kahn et al., 1991; Tsuchiya et al., 1991). The exist-
ence of three classes of ARF proteins has been proposed
based on structural relationships: class I (ARF1 and
ARF3), class II (ARF4 and ARF5), and class III (ARF6)
(Tsuchiya et al., 1991). Except for ARF6, which regulates
plasma membrane dynamics (D’Souza-Schorey et al., 1995;
Figure 5. ARF1/Q71L and wild-type ARF1 prevents redistribu-
tion of membrane-bound AP-3 to the cytosol. HeLa cells were
transiently transfected with HA-tagged ARF1/Q71L (A–F) or
HA-tagged wild-type ARF1 (G and H), and then fixed without
further treatment (A and B), or after exposure for 30 min to 2 mg/ml
BFA (C and D) or 50 mM DOG/0.4% sodium azide in RPMI/5%
FBS (E–H). Cells were double labeled for the HA epitope
(mouse anti-HA) (A, C, E, and G), and AP-3 (rabbit anti-d) (B,
D, F, and H). Cy2- or Alexa 488-conjugated anti-mouse, and
Cy3-conjugated anti-rabbit secondary antibodies were used. Cells
were visualized by confocal immunofluorescence microscopy.
Bar, 10 mm.Ooi et al. ARF1 Regulates AP-3 Membrane Association 397
Peters et al., 1995; Radhakrishna et al., 1996; Radhakrishna
and Donaldson, 1997), the other ARF family members have
not been functionally characterized. To determine if AP-3 is
regulated specifically by ARF1, we tested other ARFs for
regulation of AP-3 membrane localization in cells.
ARF3 is the ARF family member most closely related
to ARF1 (96% amino acid identity between the two pro-
teins) and a function has not been ascribed to it. One sce-
nario is that ARF3 also regulates AP-3 in cells, but even
more potently than ARF1, and could thus be a physiologi-
cal regulator of AP-3. To test this possibility, we assessed
the effect of overexpressed wild-type ARF3 on AP-3 lo-
calization in energy-depleted cells. Since wild-type ARF1
was not very potent in this setting (see above, Fig. 5, G and
H), this assay would allow revelation of higher effective-
ness of ARF3 relative to ARF1, if such were the case. We
found, however, that ARF3 had a barely discernible pro-
tective effect on AP-3 in this assay (data not shown); thus,
its effect was weaker than that of ARF1.
We next examined the role of ARF5, a class II ARF, in
AP-3 localization. A dominant-negative mutant of ARF5,
HA-tagged ARF5/T31N, was transiently transfected in
HeLa cells to inactivate endogenous ARF5. In cells ex-
pressing ARF5/T31N at levels comparable to those seen
for ARF1/T31N in Fig. 4 A, AP-3 distribution was unaf-
fected (Fig. 6, A and B). However, in cells expressing very
high levels of this mutant, AP-3 showed some cytosolic
staining, although punctate structures were still visible
(Fig. 6, A and B). Thus, ARF5/T31N apparently has the
ability to affect AP-3 distribution, but is less potent than
ARF1/T31N. To further examine the role of ARF5, we
tested the effect of a constitutively active mutant of ARF5
analogous to ARF1/Q71L. HeLa cells were transfected
with HA-tagged ARF5/Q71L, and then subjected to either
BFA treatment or energy-depletion. Treatment of ARF5/
Q71L-expressing cells with BFA resulted in retention of
COPI on Golgi/vesicular membrane structures (data not
shown), but did not prevent AP-3 membrane dissociation
(Fig. 6, C and D). Similarly, expression of ARF5/Q71L did
not protect AP-3 from membrane dissociation induced by
energy depletion (Fig. 6, E and F).
Finally, we assessed the effect of inactivating endoge-
nous ARF6. As expected, expression of the dominant-neg-
ative mutant ARF6/T27N, even at very high levels, did not
have any effect on AP-3 distribution (Fig. 6, G and H).
These results indicate that although other ARF family
members may affect AP-3 distribution in some settings,
their effects are generally much weaker as compared with
ARF1. Thus, ARF1 is most likely the ARF species that
regulates AP-3 in cells.
Visualization of ARF1 on AP-3–containing Structures
The visualization of ARF1 on AP-3–associated intracellu-
lar structures would constitute another piece of evidence
in support of a role for ARF1 in regulation of AP-3 mem-
brane association. To specifically detect ARF1 in cells, we
transfected cells with HA epitope-tagged ARF1 and
stained for the HA epitope. HA-tagged ARF1 was seen
both at the Golgi and in the cytosol, and also on weakly
stained punctate structures distributed throughout the cell,
especially in areas where cytosolic staining was less in-
tense. Some of these structures appeared to stain with AP-3
antibodies, but assessment of colocalization was hampered
by difficulty of detecting the weak ARF1 punctate staining
superimposed upon the more intense cytosolic and Golgi
staining. We found, however, that we could enhance visu-
Figure 6. Effect of ARF5 and ARF6 mutants on subcellular dis-
tribution of AP-3. HeLa cells were transiently transfected with
HA-tagged ARF5/T31N (A and B), ARF5/Q71L (C–F), or
ARF6/T27N (G and H), and then fixed without further treatment
(A, B, G, and H), or after exposure for 30 min to 2 mg/ml BFA (C
and D) or 50 mM DOG/0.4% sodium azide in RPMI/5% FBS (E
and F). Cells were double labeled for the HA epitope (mouse
anti-HA) (A, C, E, and G) and AP-3 (rabbit anti-d) (B, D, F, and
H). Cy2- or Alexa 488-conjugated anti-mouse, and Cy3-conju-
gated anti-rabbit secondary antibodies were used. Cells were vi-
sualized by confocal immunofluorescence microscopy. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 398
alization of the ARF1 punctate structures by treatment of
cells with aluminum fluoride before fixation. Aluminum
fluoride is a G protein activator that affects behavior of
ARF1 and ARF6 vis-à-vis their distribution or effect on
coat proteins (Donaldson et al., 1991; Finazzi et al., 1994;
Radhakrishna et al., 1996), either via an indirect effect on
upstream G proteins or via a direct effect on ARF itself.
Treatment of HeLa cells with aluminum fluoride in-
creased the number and size of the ARF1-associated
punctate structures, allowing us to observe the presence of
AP-3 on many of them (Fig. 7, A and B). Similar experi-
ments performed with HA-tagged ARF3 and ARF5 stain-
ing revealed predominant staining in the cytosol and Golgi
region with little or no colocalization with AP-3 (data not
shown). Thus, of the three ARF species examined, colo-
calization with AP-3 was most readily observed for ARF1.
Differential Effects of BFA on ARF1-regulated Coats 
in MDCK Cells
The three distinct coats (COPI, AP-1, and now AP-3) that
are regulated by ARF1 are involved in different transport
pathways, and thus need to be independently regulated. In
MDCK cells, the Golgi coat COPI is resistant to the ef-
fects of BFA (Hunziker et al., 1991), presumably due to in-
sensitivity of the Golgi ARF1 GEF to this drug. This thus
provides a setting in which to explore independent behav-
ior of different ARF1-regulated coats. When MDCK cells
were treated with BFA, COPI Golgi association was unaf-
fected (Fig. 8, A and B), as expected. In contrast, AP-3 was
BFA sensitive, and was redistributed from its punctate
structures to the cytosol (Fig. 8, C and D). AP-1 was also
sensitive to BFA in these cells, as has been reported (Wag-
ner et al., 1994), and was redistributed from the Golgi to the
cytosol (Fig. 8, E and F). The differential effects of BFA on
these different coats suggest that their ARF1-dependent
regulation may be mediated by distinct ARF1 GEFs with
differential sensitivity toward this drug.
Discussion
In this study, we demonstrate that ARF1 regulates associ-
ation of the recently identified adaptor AP-3 with mem-
branes. Using an in vitro biochemical approach, we found
that AP-3 could be recruited from cytosol to membranes.
Binding of AP-3 to membranes was saturable, implying
recognition by a limiting protein component on mem-
branes. Consistent with this, a protein factor(s) was found
to be required for binding of AP-3 to membranes. Such a
factor could be an ARF1 receptor (e.g., ARF1 GEF) since
we also find that ARF1 binding to membranes is abolished
upon inactivation of membrane proteins. Another candi-
date for the required membrane protein is a putative re-
ceptor or docking protein for AP-3. Binding of AP-3 to
membranes was stimulated by GTPgS and inhibited by
BFA, consistent with it being regulated by ARF1. The in-
hibition by BFA was partial, as has been observed for
other coat proteins (Donaldson et al., 1992; Palmer et al.,
1993; Stammes and Rothman, 1993; Dittie et al., 1996);
this could be due to nonoptimal assay conditions or some
ARF-independent binding of AP-3. Direct demonstration
of a requirement for ARF1 was provided by the ability of
purified recombinant myristoylated ARF1 to promote
binding of AP-3 to membranes.
The role of ARF1 in vivo was assessed by altering intra-
cellular levels of ARF1-GTP through overexpression of
ARF1, or of dominant mutants or regulators of ARF1. In-
activation of intracellular ARF1 by high-level expression
of either the dominant-negative mutant ARF1/T31N or of
ARF1-GAP resulted in dissociation of AP-3 from mem-
brane-bound structures. Although these experiments im-
plicate involvement of ARF1 in membrane association of
AP-3, it is possible that the observed effects reflect inhibi-
tion of a similar but distinct ARF1-related regulator of
AP-3. To address this issue, we demonstrated a direct role
for ARF1 by showing that high level expression of a con-
stitutively active ARF mutant (ARF1/Q71L) could over-
come the effects of pharmacologic agents or treatments
that induced dissociation of AP-3 from membranes. The
protective effect of ARF1/Q71L was seen in experiments
using two distinct treatments for promoting AP-3 dissocia-
tion from membranes, namely BFA, and energy depletion.
Furthermore, expression of wild-type ARF1 itself, albeit
at extremely high levels, was able to confer protection
from the effects of energy depletion. Although BFA acts
by affecting ARF1-GTP status, it is not known how energy
depletion causes AP-3 dissociation. The ability of ARF1/
Q71L to overcome the effects of energy depletion, how-
ever, does not necessarily point to a direct effect of this
manipulation on ARF1 status (see below). Rather, since
Figure 7. Visualization of ARF1 on AP-3 con-
taining structures. HeLa cells were transiently
transfected with HA-tagged wild-type ARF1 and
treated with 50 mM AlCl3/30 mM NaF for 30 min
at 378C, fixed, and then stained with antibodies to
HA (mouse anti-HA) (A) or AP-3 (rabbit anti-d)
(B), followed by Alexa 488-conjugated anti-
mouse and Cy3-conjugated anti-rabbit antibod-
ies. Cells were visualized by confocal immunoflu-
orescence microscopy. Arrows, structures that
stain for both ARF1 and AP-3. Bar, 5 mm.Ooi et al. ARF1 Regulates AP-3 Membrane Association 399
the interplay of multiple factors (Le Borgne et al., 1996;
Rapoport et al., 1997) probably determines coat bind-
ing, ARF1/Q71L expression could compensate indirectly
by shifting the equilibrium of one of the factors, i.e.,
ARF1-GTP.
Taken together, the biochemical evidence and in vivo
studies indicate that ARF1-GTP promotes the association
of AP-3 with membranes. Our observation that activated
ARF1 can be found on intracellular AP-3–associated
structures provides circumstantial evidence in further sup-
port of this conclusion. Since AP-3 is involved in transport
within the endosomal–lysosomal system (Cowles et al.,
1997; Ooi et al., 1997; Stepp et al., 1997; Faúndez et al.,
1998), the punctate ARF1 structures that also stain for
AP-3 probably correspond to endosomal structures.
The finding that AP-3 is regulated by ARF1 contributes
to the notion that, of the clathrin adaptor complexes, AP-2
is in a separate class distinct from AP-1 and AP-3. Al-
though AP-2 can be recruited to membranes by ARF1 or
GTPgS, this can only be achieved in vitro, and appears to
reflect mistargeting under nonphysiological conditions
(Seaman et al., 1993; Traub et al., 1993; West et al., 1997).
Previous studies (Robinson and Kreis, 1992; Wong and
Brodsky, 1992) have pointed to differences between AP-1
and AP-2 recruitment in vivo with respect to sensitivity to
BFA and GTPgS. This is probably a reflection of differ-
ences in ARF1 requirement in vivo. We have found that
membrane recruitment of AP-2 also differs from that of
AP-3 in that conditions which induce AP-3 dissociation
from membranes, namely ARF1 inactivation, energy de-
pletion, and lowered temperature (158C), have no effect
on AP-2 membrane association (data not shown). Using
similar criteria, we also find that requirements for AP-1
membrane recruitment differ from that for AP-3, even
though both of these complexes are regulated by ARF1.
AP-1, like AP-3, was rendered cytosolic by energy deple-
tion, but unlike AP-3, remained mostly membrane bound
at 158C (data not shown). Thus, the three adaptor com-
plexes each display a distinct profile when assessed using a
panel of factors affecting membrane localization. The sen-
sitivity of AP-3 to energy depletion in vivo (which lowers
both ATP and GTP levels) may reflect involvement of
events such as protein phosphorylation as well as the re-
quirement for ARF. The effect of lowered temperature
could be a change in the properties of proteins or lipids
that interact with AP-3 or are specific to the AP-3 path-
way. In fact, the observation that 158C treatment blocks
traffic out of endosomal intermediates but not endocytosis
from the plasma membrane (Singer and Riezman, 1990;
Desnos et al., 1995) may be explained in part by our find-
ing that AP-2 and AP-3 respond differently to 15oC treat-
ment, and by a possible role for AP-3 in the endosomal
transport pathway.
The existence of several ARF family members initially
led to the idea that different ARF proteins might regulate
distinct protein coats and thus different transport path-
ways. However, ARF1, which was found initially to pro-
mote binding of the nonclathrin coat COPI to membranes
(for reviews see Donaldson and Klausner, 1994; Boman
and Kahn, 1995) was then found to have the same function
for a clathrin coat (AP-1) (Stammes and Rothman, 1993;
Traub et al., 1993; Dittie et al., 1996). In addition, ARF1
has been reported to be required for endosome–endosome
fusion (Lenhard et al., 1992) and for synaptic vesicle bio-
genesis from endosomes (Faundez et al., 1997). Here, we
find that ARF1 is also required for membrane association
of another adaptor, AP-3, believed to function in the en-
dosomal–lysosomal system. Indeed, ARF1 has been de-
tected in endosomal fractions, and may be responsible for
recruiting COPI to endosomes (Whitney et al., 1995;
Aniento et al., 1996). Thus, the emerging picture is that
ARF1 regulates many different coat proteins, refuting a
‘one ARF-one coat’ paradigm. As a consequence of its ef-
fect on multiple coats, ARF1 appears to be a regulator of
diverse membrane transport systems within the cell. Such
a concept has also been derived from studies showing ef-
fects of BFA on the Golgi and the endosomal–lysosomal
system (Lippincott-Schwartz et al., 1991), as well as from
recent studies with a yeast arf mutant, which indicate that
Figure 8. Comparison of the effect of BFA on different ARF1-
dependent coat proteins in MDCK cells. MDCK II cells were
fixed without previous treatment (A, C, and E) or after exposure
to 2 mg/ml BFA for 30 min at 378C (B, D, and F). Cells were
stained with antibodies to COPI (rabbit anti–b-COP) (A and B),
AP-3 (rabbit anti-d) (C and D), and AP-1 (mouse anti-g) (E and
F), followed by Cy3-conjugated anti-mouse or anti-rabbit anti-
bodies. Cells were visualized by confocal immunofluorescence
microscopy. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 400
the orthologue of ARF1 in yeast is required for mainte-
nance of both Golgi and endosome structure and function
(Gaynor et al., 1998).
The finding that ARF1 regulates three different coats,
COPI, AP-1, and now AP-3, reinforces the idea that
ARF1 is not a regulator of specific coats, but rather a com-
mon molecular switch that transduces signals from up-
stream modulators of coat assembly. A candidate for such
a modulator is the ARF1 GEF that activates ARF1 by
guanine nucleotide exchange. Four different cytosolic and/
or Golgi ARF1 GEFs have recently been identified (Char-
din et al., 1996; Rosa et al., 1996; Meacci et al., 1997; Mori-
naga et al., 1997), and a Golgi membrane-associated
ARF1 GEF has been described but not yet isolated
(Donaldson et al., 1992; Helms and Rothman, 1992; Ran-
dazzo et al., 1993). It is possible that activation of ARF1 by
these distinct GEF proteins leads to recruitment of differ-
ent coat proteins. In support of such a scenario, we find in
MDCK cells that two ARF1-regulated coats, COPI and
AP-3, display differential sensitivity to BFA. Since BFA
appears to be an inactivator of ARF1 GEF, this implies
the existence of distinct ARF1 GEFs that control different
coats via ARF1. In addition, two Golgi-localized ARF1-
regulated coats, COPI and AP-1, also display differential
sensitivity to BFA (Wagner et al., 1994; this study). Thus,
different subdomains of an organelle can exhibit indepen-
dent ARF1-regulated events.
The GTPase-activating protein ARF1-GAP is another
ARF1 regulatory protein that may represent a modulator
of ARF1 activity that is specific for a particular coat. We
cannot distinguish at present whether the effect of the
Golgi-localized ARF1-GAP on AP-3 in our experiments is
due to a direct or indirect effect of ARF1-GAP. Conceiv-
ably, the latter case could arise from sequestration of the
pool of available intracellular ARF1 by cytosolic overex-
pressed ARF1-GAP. Finally, the finding that the KDEL
receptor ERD2 regulates ARF1-mediated events by re-
cruiting ARF1-GAP (Aoe et al., 1997) raises the possibil-
ity that other as yet unidentified transmembrane receptors
modulate different coat proteins via ARF1-GAP.
The molecular mechanism by which ARF1 recruits coat
proteins is not known. Two prevailing views are (a) ARF
is a stoichiometric receptor for the coats themselves; and
(b) ARF acts catalytically through activation of the en-
zyme phospholipase D, locally remodeling lipids to gener-
ate sites favorable for coat protein binding (Ktistakis et al.,
1996). The finding that ARF1 is found on isolated coat
vesicles in a 3:1 molar ratio relative to COPI (Serafini et al.,
1991), and report of a direct interaction of ARF1 with the
b-COP subunit of COPI (Zhao et al., 1997) supports the
first model. Evidence for the second model is provided by
the finding that exogenous phospholipase D can recruit
coatomer to membranes and also stimulate release of na-
scent secretory vesicles from the TGN (Ktistakis et al.,
1996; Chen et al., 1997). The two models are not mutually
exclusive, and both mechanisms may be in operation.
Do other ARF family members regulate AP-3? ARF6 is
clearly distinct from all the other ARFs, based on its struc-
tural, morphological, and functional characteristics. From
our studies, it appears that ARF3, while apparently able to
affect AP-3 localization, is a ‘weaker’ version of ARF1.
We also found that ARF5 mutants had limited or no effect
on AP-3. The much less evident colocalization of ARF3
and ARF5 with AP-3 is consistent with the results of the
functional assays. Thus, although different ARFs appear
to be able to substitute functionally for ARF in yeast arf
mutants (Stearns et al., 1990; Kahn et al., 1991), and have
similar in vitro activities (Liang and Kornfeld, 1997), they
do not appear to be strictly redundant in mammalian cells
in vivo.
The recruitment of coat proteins to their appropriate in-
tracellular membranes is a critical step in the initiation of a
transport event. It is dependent upon the interplay of mul-
tiple molecular interactions that are coordinated by the
adaptor complex which itself is a component of the coat.
The conclusions of this study contribute to the concept of
ARF as a common molecular switch in the different regu-
latory pathways that govern this process for distinct coats.
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